Skip to main content

Edwards Lifesciences Corp

EW
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001099800

In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 10 sales; 1,344 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.

Superinvestors holding EW, Q2 2026

See all superinvestors

No superinvestor reported holding EW in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of EW each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    0 superinvestors holding at quarter end

    Sold out
    Viking Global Investors
  2. Q1 2026

    1 superinvestor holding at quarter end

    New
    Viking Global Investors
  3. Q4 2025

    0 superinvestors holding at quarter end

    Sold out
    Viking Global Investors
  4. Q3 2025

    1 superinvestor holding at quarter end

    New
    Viking Global Investors
  5. Q1 2025

    0 superinvestors holding at quarter end

    Sold out
    Soros Fund Management, Giverny Capital
  6. Q4 2024

    2 superinvestors holding at quarter end

    Reduced
    Soros Fund Management (−16.7%), Giverny Capital (−99.9%)
    Sold out
    Maverick Capital
  7. Q3 2024

    3 superinvestors holding at quarter end

    New
    Soros Fund Management, Maverick Capital
    Added
    Giverny Capital (+0.1%)
  8. Q2 2024

    1 superinvestor holding at quarter end

    Added
    Giverny Capital (+0.1%)
    Sold out
    Soros Fund Management
  9. Q1 2024

    2 superinvestors holding at quarter end

    New
    Soros Fund Management
    Added
    Giverny Capital (+1.1%)
    Sold out
    Maverick Capital
  10. Q4 2023

    2 superinvestors holding at quarter end

    Added
    Giverny Capital (+0.1%)
    Reduced
    Maverick Capital (−43.9%)
  11. Q3 2023

    2 superinvestors holding at quarter end

    Added
    Giverny Capital (+0.2%), Maverick Capital (+22.9%)
  12. Q2 2023

    2 superinvestors holding at quarter end

    Added
    Giverny Capital (+6.0%)
    Reduced
    Maverick Capital (−39.5%)
    Sold out
    Fundsmith
  13. Q1 2023

    3 superinvestors holding at quarter end

    Added
    Maverick Capital (+96.9%)
    Reduced
    Giverny Capital (−2.6%)
  14. Q4 2022

    3 superinvestors holding at quarter end

    Reduced
    Giverny Capital (−0.9%), Maverick Capital (−74.6%)
  15. Q3 2022

    3 superinvestors holding at quarter end

    New
    Maverick Capital, Fundsmith
    Added
    Giverny Capital (+3.2%)
  16. Q2 2022

    1 superinvestor holding at quarter end

    Added
    Giverny Capital (+2.9%)
  17. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    Giverny Capital (−0.2%)
  18. Q4 2021

    1 superinvestor holding at quarter end

    Added
    Giverny Capital (+0.9%)
    Sold out
    D1 Capital Partners
  19. Q3 2021

    2 superinvestors holding at quarter end

    Reduced
    Giverny Capital (−0.8%), D1 Capital Partners (−90.5%)
  20. Q2 2021

    2 superinvestors holding at quarter end

    Added
    D1 Capital Partners (+1.7%), Giverny Capital (+3.9%)